The generalized model of the blood glucose/insulin concentration in an insulin-dependent diabetic patient where the patient has variable pancreatic response lo glucose level was considered. It was shown that greater response of the pancreas to glucose concentration leads to quicker clearance of excess glucose In the blood. Also, the gleatest quantity of glucose to be found at any time when the response is high is less when compared with that of lower response of the pancreas to the glucose level. Another disturbing result is the? fact that if the pancreatic response to glucose level (and thus level of insulin release) is non-steady, we then have dual or multiple peak of insulin level, v!,iich present variable insu!in production for those with higher pancreatic response This results to problem as regards the conversion mode of the gtucose to glycogen. The consequence of this is that the patient might be exposed to such sltuat~ons like low b!aod glucose level and might then suffer hypoglycemia if proper diagnosis was not made to determine the exect diabetic level or severity.
concentration usually results to micro-vascular complications of which the most importantly affected parts qf the numan system are the eyes and the kidney. (Czech and Massagnes, 1982 ;  Vallence-Owen. 1975 ).
There are various causes of diabetes mellitus though they are put into tw:, broad forms: insulin -dependent and t,le non-insulin -dependent. Of particular interest in this work is ilie insulin-dependent form. The insulindependent diabetes mellitus is a type of disease caused by low insulin concentration in !he blood piasma of which the simplest approach to treatment is the insulin infusion or administration. Insulin is a hormone secreted by the islet of langerhans of the pancreas. It has wide spectrum of .activities among, which is the enhancement of the cell conversion of the excess glucose in the plasma to glycogen, which is the storable forin of glucose in the body organs and cells (MSah, 1998 ) . It is this particular attribute of the insulin that is usually lacking in an insulin-dependent diabetic patient. In norma! persons, carbohydrate taken as food is digested in the alimentary canal from where the glucose and other monosacharides are absorbed into the blood. From the blood, they diffuse into the extra-cellular fluids. 0 facilitated-Y mediated transport process, this glucose is taken to the cell plasma membrane by the carrier proteins ca led glucose transporters (Simpson and Cushman, 1985.) : About six of such glucose transporters have been identified (Beil et 4 , 1989) . The cell membrane structure shows that the outer surface of the plasma membrane is lined with. evenly distribution protein receptors fo'ihormones and other chemical messengel s (Czech and ~assagne's, 1982 , Gavin et al , 1974 , Kosmokos and Roth, 1980 , Lorinth and Smith, 1983 . This makes the plasma membrane a signal -receiving device for the detection of chemical signals that regulate the cell activitie.~. It is at this membrane that the insulin performs its function by binding with these receptor proteins either in phosphorylated or unphosphorylated forrrs. It is this autophosphorylation action of the insulin that-~causes the aggregation of the protein receptors at the plasma membrane (Quon and Campfield , 1985) . This reduces the inhibitory action of these proteins to the entry of glucose ~nto the cells. Although the exact mechanism of glucose entry into the cells is not clearly known, it is-thought that the glJcose, through the facilitated-mediated transport, gets to the plasma rnembiane where they bind with the appropriate carrier proteins leading to conformal changes in the carrier molecules that will now allow thepassage of !he glucose. Though this is what happens in the blood1 cells of a normal person, it is not exactly the same. in an ~nsulin-dependent diabetic patient. In this case, there is usually law concentration of insulin in the plasma. This affects the proper functioning of the insulin with particular reference to the plasma gli~cose regulation, (Rute, 1982) . Usually !he low plasma insulin concentration is occasioned by reduced response of the pancreatic cells to produce/release insulin when stimulated by high plasma glucose concentration,This action leads to reduced interaction of the plasma glucose and insulin and thus the high plasma concentration of the glucose.
A mathematical model showing the variation in the level of the glucose or insulin in the blood of an insullndependent diabetic patient was presented ( Mbah, 1998 ) .
In summarized form we state the factors that affect the levels of glucose and insulin in the blood at all times. We have that-fos the blood glucose level, the factors that determines it are.
the quantity of food taken, . .
. % glucoselinsulin interact~an (in other words the glucose conversion to glykogen due to peripheral cell response), the amount of this glucose being converted to energy and finally the release of the stored glycogen by the liver for a long period of no food-intake.
For the insulin level, we see that the factors are the pancreatic cell response to the level of glucose in the blood, the Insulin usage and the insulin infusion because the patient is diabetic. Detailed study on the derivation of the mathematical m-giels can be obtained in ~b a h '(1998), Mbah (2001).
The resulting mathematical models are: gati ion (1) as presented is a general case but we shall assume that the patient is not starving so that a4 (xo -x) will be neglected. Thus our equations of interest will be Now a look at equation (3) shows :hat it is non-linear. However, sincee@patient is not starving meaning that there is always enough glucose in the b6od to be converted to glycogen in the presence of insulin, we may linearize the term .v lo Fy where 2 is now a constant. With this, equation (3) now becomes a linear differential equation and given as:
Method of solution
The equations (4 ) and (5) 
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In equaions ( 6 ) and (7), a, and b, measures the glucose and insulin interaction and the pancreatic'respona to the glucose stimulation respectively. Hence, the severity of the patient's diabetes depends principally on how smal the value of b, is and also on the value of a,. These two equations are solved simultaneously by finding thei:
complementary and particular solutions which when added up give their solutions. Suppose ~e complementar! solutions (x,y) = (xc,yc) to the homogenous equations. dx
is given by From equations (8) and (9) we have the matrix of coefficients as
The eigefi-values A, and hZ of matrix T are got by snk'ing for A in the determinantal equation
Hence, we have -(a, +4)* {(a, +b2), L
+~~b , f ) }~
We must find :he particular solutions for the equations in terms of, z(t) and o(t) respectively.' Let these particut; solutions be denoted by Thus, for z (t), we solve to get the particular solution as:
For. w(t), we also, solve to get the particular solution as
where m=a& +ah2
In general therefore, the solution to the equation is When eflations (10), (13) and (14) are substituted into equation (l5) Here, t' represents the time of interest and can as$ume various values as we may desire such as 1' = to which in this case will mean wishing to k n o w~h a t happens to the glucose and insulin levels at the beginning of the experiment denoted by b. The essence of the time 1' other'than t, 1s that E, and E, are to be d e t m~n e d at times other than b most especially as we now have insulin infusion to determine the plasma glucose and insulin kvek. Recall from the expression for the o(t) that insulin has.a 1% value that presents different glucose response to the kvels of the insulin at such a time. The x* and y* stands for the amount of glucose and insulin in the plasma at such a time t* respectively. The change in x* and y' have the same importance as stated in the case oft*.
ANALYSIS

I
In the analysis here, we wish to see what happens for a case where the pancreatic insulin 'release varies. By this, it can be likened to looking at the blood glucose/insulin levels of diabetic patients of different levels of severity that are being fed sim~larly with similar insulin infusion. It can also be likened to a diabetic patient whose insulin release is not Steady but varies at different times within the same period of feeding. The~retically, we know that if two patients of different levels of severity are fed with the same quant~ty of food (same glucose worth) and treated with equal quantity of insulin; they will present reactions tl; this and will have different levels of glucoselinsulin, differing clearance time of ths glucose etc.
Ysing the model and the resulting solution, we tried to replicate this result. Ih figure ( I ) , we considered a case where z l . b3. a2 an4 a3 are constant while bl varies. The values of a2, a3, b2, b3 are given: From the graph, we can see that 'ar b, = 0.05, 0.1, 0.2 and 0.25,we can see that both the glucose levels and the clearance time varied. For bl = 0.25, In fig. (2) , we show the corresponding insulin level in the blood for the value of bl and a2, a2, b2, bs as used above. We c g~ see from this graph that for bl > 0.1, the resulting curves became crooked. What this mearls is that at this level of diabetes, the pancreas has the capacity to produce insulin and this capacity has to be respected ir; trying ' to treat such diabetic patient by insulin infusion. Because of the infused insulin the pancreas insulin release is inhibited . until this infused one is exhausted and the pancreas will then start to release insulin because of the demand for more insulin due to the level of excess glucose in the blood that is not yet converted. The biological implication of varied pancreatic response to glucose level in the blood is that we will not be sure of the state of health of the patient. If enough quantity of food is not taken by such a patient and insulin is infused, such a patient might suffer hypoglycemia as the subsequent released insulin will reduce the blood glucose level to such a low level. Therefore, we may conclude that for such a patient, it will be very difficultto control the blood glucose level since the insulin release and thus its level in the blood cannot be correctly predicted. Even the quantity of the insulin to be infused cannot also be correctly measured. Pancreatic varied insulin release should -therefore be considered and handled with all sense of seriousness wherever and whenever it is noticed in any patient
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